AdvanDx develops and markets molecular-based,
in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available within hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations.
More About Us
6.2.2009 | First hospital in Georgia to use a new, cutting edge diagnostic technology to fight serious infections and improve patient care and...
5.15.2009 | Test results to establish Group B Strep colonization of pregnant women and help clinicians guide antibiotic therapy to prevent infections in...
5.5.2009 | First Diagnostic Test for Identifying E. coli, K. pneumoniae and P. aeruginosa Directly from Positive Blood Cultures. PNA FISH Provides...
